An in vitro system for the editing of apolipoprotein B mRNA - PubMed (original) (raw)
An in vitro system for the editing of apolipoprotein B mRNA
D M Driscoll et al. Cell. 1989.
Abstract
A novel form of RNA editing generates two forms of apolipoprotein B (apo-B) mRNA by converting C at nucleotide 6666 to U or a U-like base. We have established an in vitro system for the editing of apo-B mRNA using synthetic RNAs and S100 extracts from rat hepatoma cells. Editing was detected by a sensitive primer extension assay and confirmed by DNA sequencing. The in vitro editing activity is specific and sensitive to proteinase K. Apo-B100 RNAs were synthesized in vitro from deletion mutants spanning nucleotide 6666. Synthetic RNAs containing 2383, 483, and 55 nucleotides of apo-B mRNA sequence were edited in vitro with similar efficiency, but an RNA containing 26 nucleotides was not edited.
Similar articles
- RNA editing: a novel mechanism for regulating lipid transport from the intestine.
Scott J, Wallis SC, Davies MS, Wynne JK, Powell LM, Driscoll DM. Scott J, et al. Gut. 1989 Nov;30 Spec No(Spec No):35-43. doi: 10.1136/gut.30.spec_no.35. Gut. 1989. PMID: 2606364 Free PMC article. - Sequence requirements for apolipoprotein B RNA editing in transfected rat hepatoma cells.
Davies MS, Wallis SC, Driscoll DM, Wynne JK, Williams GW, Powell LM, Scott J. Davies MS, et al. J Biol Chem. 1989 Aug 15;264(23):13395-8. J Biol Chem. 1989. PMID: 2760026 - Induction of RNA editing at heterologous sites by sequences in apolipoprotein B mRNA.
Driscoll DM, Lakhe-Reddy S, Oleksa LM, Martinez D. Driscoll DM, et al. Mol Cell Biol. 1993 Dec;13(12):7288-94. doi: 10.1128/mcb.13.12.7288-7294.1993. Mol Cell Biol. 1993. PMID: 8246950 Free PMC article. - Apolipoprotein B mRNA editing: a new tier for the control of gene expression.
Hodges P, Scott J. Hodges P, et al. Trends Biochem Sci. 1992 Feb;17(2):77-81. doi: 10.1016/0968-0004(92)90506-5. Trends Biochem Sci. 1992. PMID: 1373530 Review. - Apolipoprotein B mRNA editing: a key controlling element targeting fats to proper tissue.
Davidson NO. Davidson NO. Ann Med. 1993 Dec;25(6):539-43. Ann Med. 1993. PMID: 8292303 Review.
Cited by
- Identification of RBM46 as a novel APOBEC1 cofactor for C-to-U RNA-editing activity.
Wang S, Kim K, Gelvez N, Chung C, Gout JF, Fixman B, Vermulst M, Chen XS. Wang S, et al. J Mol Biol. 2023 Dec 15;435(24):168333. doi: 10.1016/j.jmb.2023.168333. Epub 2023 Oct 29. J Mol Biol. 2023. PMID: 38708190 - Unraveling the Enzyme-Substrate Properties for APOBEC3A-Mediated RNA Editing.
Kim K, Shi AB, Kelley K, Chen XS. Kim K, et al. J Mol Biol. 2023 Sep 1;435(17):168198. doi: 10.1016/j.jmb.2023.168198. Epub 2023 Jul 11. J Mol Biol. 2023. PMID: 37442413 Free PMC article. - The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness.
Kim K, Calabrese P, Wang S, Qin C, Rao Y, Feng P, Chen XS. Kim K, et al. Sci Rep. 2022 Sep 13;12(1):14972. doi: 10.1038/s41598-022-19067-x. Sci Rep. 2022. PMID: 36100631 Free PMC article. - The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness.
Kim K, Calabrese P, Wang S, Qin C, Rao Y, Feng P, Chen XS. Kim K, et al. Res Sq [Preprint]. 2022 Apr 12:rs.3.rs-1524060. doi: 10.21203/rs.3.rs-1524060/v1. Res Sq. 2022. PMID: 35441170 Free PMC article. Updated. Preprint. - The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness.
Kim K, Calabrese P, Wang S, Qin C, Rao Y, Feng P, Chen XS. Kim K, et al. bioRxiv [Preprint]. 2022 Apr 7:2021.12.18.473309. doi: 10.1101/2021.12.18.473309. bioRxiv. 2022. PMID: 34981048 Free PMC article. Updated. Preprint.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous